# GHK-Cu: The Copper Tripeptide, Read Against the Record

> GHK-Cu is the copper(II) chelate of glycyl-histidyl-lysine. Copper coordination is required for most of its documented matrix-remodeling activity. A cited critical digest.

The matrix-remodeling work is real and reproducible in vitro; the human data is topical and thin. This is the record, set in plain type, with every number cited.

## What the GHK-Cu record establishes

GHK-Cu is the glycyl-L-histidyl-L-lysine copper(II) complex — a three-amino-acid peptide that carries one copper ion. It occurs naturally in human plasma, saliva, and urine, where the free tripeptide was first isolated in 1973 as a factor that made aged liver tissue synthesize protein like younger tissue [2]. The molecular weight of the complex is 402.92 Da; the free peptide is 340.38 Da [2]. The 62-dalton difference is the whole story of this site: copper coordination is what turns an unremarkable tripeptide into a matrix-remodeling signal.

The single most load-bearing result in the literature is a negative one. In fibroblast cultures, GHK-Cu stimulated matrix metalloproteinase-2 expression with concurrent upregulation of its TIMP inhibitors — and the free GHK tripeptide did not reproduce the effect [7]. The copper-bound form is required. Most of what follows on this site flows from that single finding, and it is why the form a given study used is the first thing worth checking.

Where the data is precise, it is striking. In human fibroblast cultures, GHK-Cu stimulated collagen synthesis beginning between 10^-12 and 10^-11 M and peaking near 10^-9 M, with no change in cell number — a specific metabolic effect, not faster-growing cells [1]. A skin-regeneration review reports that topical GHK-Cu increased collagen production in 70% of treated women, versus 50% for vitamin C and 40% for retinoic acid [3]. Gene-expression analysis reports GHK alters expression of about 31.2% of human genes at a 50%-or-greater change threshold [4]. These are study findings in cell culture and small topical trials — not a treatment plan.

Where the data is honest, it is thin. There is no validated human pharmacokinetic profile — no measured half-life, Cmax, or bioavailability — for injectable or systemic GHK-Cu [6]. A large share of the foundational mechanistic and review literature comes from one investigator's group, so independent replication of the broader claims is limited. This site reads that gap as plainly as it reads the findings.

## GHK Copper Peptide: What the Research Describes

GHK copper peptide is the most-studied member of the copper-peptide class. The sequence — glycine, histidine, lysine — is not arbitrary: it occurs endogenously within the alpha-2(I) chain of type I collagen and in the matricellular protein SPARC, which means injured tissue can liberate it locally during repair [6]. When SPARC is cleaved, it releases copper-binding peptides including GHK and the more potent KGHK that stimulate angiogenesis [8]. The peptide is, in other words, part of the body's own repair vocabulary.

As a copper chaperone, GHK forms a high-affinity 1:1 complex with copper(II) coordinated through the histidine imidazole nitrogen, the glycine alpha-amino nitrogen, and a deprotonated amide nitrogen, leaving the lysine side chain free [2]. That geometry stabilizes the copper — the complex has a stability constant of roughly log K 16.4 — which limits pro-oxidant free-copper release while still delivering copper to the enzymes that need it. The foundational tissue-remodeling review catalogs the full profile: increased synthesis of collagen, elastin, metalloproteinases, anti-proteases, VEGF, FGF-2, and neurotrophins, alongside suppression of free radicals, TGF-beta-1, TNF-alpha, and protein glycation, with macrophages and capillary cells chemoattracted to the repair site [6].

From that overview, this site branches into [how copper peptides work](/how-copper-peptides-work) at the mechanism level, into [copper tripeptide-1](/copper-tripeptide-1) for the GHK-versus-GHK-Cu distinction, and into the [GHK-Cu research findings](/research) by tissue.

## What Is a Copper Peptide?

A copper peptide is a short peptide that binds a copper ion and uses that copper as a functional cofactor. The category is broad in cosmetics but narrow in well-characterized biology: GHK-Cu is the one with a real mechanistic literature behind it. The defining feature is that the metal is not an impurity — it is the active part. Copper enables lysyl oxidase to cross-link collagen and elastin, and it underwrites a superoxide-dismutase-like antioxidant activity [6]. Strip the copper out and, in the MMP-2 assay at least, the activity goes with it [7].

That is why this site treats GHK-Cu and the bare GHK tripeptide as two different molecules with overlapping names. The literature frequently conflates them, and many studies that report systemic or gene-level effects used the free peptide. Reading the copper-peptide record well means tracking, study by study, which form was actually administered.

## What is GHK-Cu and how does it work?

GHK-Cu is the glycyl-L-histidyl-L-lysine copper(II) complex, a copper-binding tripeptide that acts as both a copper chaperone and a pleiotropic signaling molecule. At picomolar-to-nanomolar concentrations it directly stimulates dermal fibroblast synthesis of collagen, elastin, and glycosaminoglycans, rebalances matrix metalloproteinases against their TIMP inhibitors, and broadly shifts gene expression toward repair, antioxidant, and DNA-fidelity programs [1][4].

## What does a copper peptide do for your skin?

In research models GHK-Cu stimulates fibroblast synthesis of collagen, dermatan and chondroitin sulfate, and the proteoglycan decorin; a skin-regeneration review reports topical GHK-Cu increased collagen production in 70% of treated women versus 50% for vitamin C and 40% for retinoic acid [3]. These are study findings, not a human treatment recommendation. The deeper tissue-by-tissue evidence sits on the [GHK-Cu research findings](/research) page.

## What does a GHK-Cu peptide do?

Across reviewed human and animal studies GHK-Cu stimulates wound healing and matrix remodeling, increasing synthesis of collagen, elastin, metalloproteinases, anti-proteases, VEGF, FGF-2, and neurotrophins while suppressing free radicals, TGF-beta-1, TNF-alpha, and protein glycation, and chemoattracting macrophages and capillary cells to repair sites [6]. It is a repair signal, characterized mostly in cell culture and rodents.

---

A critical broadsheet of the GHK-Cu copper-tripeptide record — what the literature confirms set in black, what it cannot yet promise stamped in the margin, with no clinic behind the masthead and nothing here to dispense.